regression and Cox proportional hazards were used. For the proportion of procedures, only centers with >20 procedures and surgeons with >10 procedures in 2016 were included.
BEST-CLI
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Objective: There is limited evidence regarding the role of multidisciplinary teams in vascular clinical trials. Best Endovascular vs Best Surgical Therapy for Patients with Critical Limb Ischemia (BEST-CLI), a randomized trial comparing surgical and endovascular revascularization strategies, is structured to foster multidisciplinary collaboration. To evaluate the impact of collaboration, we compared enrollment rates at multidisciplinary and nonmultidisciplinary sites.
Methods: We analyzed 132 BEST-CLI sites open for enrollment. Multidisciplinary sites had investigators belonging to at least two different specialties (vascular surgery and interventional cardiology or radiology). Sites having only vascular surgery investigators were considered single disciplinary. To test our hypothesis, a linear regression model of monthly enrollment rate was constructed considering the following characteristics: multidisciplinary vs single disciplinary and total number of investigators.
Results: Ninety (68%) sites were multidisciplinary and 42 (32%) sites were single disciplinary. At time of analysis, these sites had enrolled 1345 patients. The mean and median monthly enrollment at multidisciplinary sites were 0.30 and 0.24 (range, 0-1.77). The mean and median monthly enrollment at single-disciplinary sites were 0.27 and 0.24 (range, 0-1.30). In the regression model, there was no significant difference in monthly enrollment rates between multidisciplinary and single-disciplinary sites; after adjustment for the total number of investigators, multidisciplinary sites averaged 0.02 fewer enrolled per month (95% confidence interval, À0.13 to 0.09; P ¼ .72). Monthly enrollment rates were significantly higher for sites with more investigators (0.02 higher for each additional investigator (95% confidence interval, 0.00-0.03; P ¼ .0497).
Conclusions: Clinical enrollment rates in randomized trials are affected by multiple factors. After adjusting for the total number of investigators, we found no significant relationship between multidisciplinary status and monthly enrollment rates. Monthly enrollment rate was positively correlated with number of site investigators. Given the importance of enrollment for trial execution, further evaluation of factors that have an impact on enrollment is crucial. Objective: Blunt abdominal aortic injury (BAAI) occurs in <0.1% of blunt trauma. A previous multi-institutional study found an associated mortality rate of 39%. We sought to identify risk factors for BAAI and risk factors for mortality in patients with BAAI using a large national database.
Methods: The Trauma Quality Improvement Program (2010-2016) was queried for individuals with blunt trauma. Patients with and without BAAI were compared. Covariates were included in a multivariable logistic regression model to determine mechanisms of injury, examination findings, and concomitant injuries associated with increased risk for BAAI. A multivariable analysis was performed for mortality in patients with BAAI.
Results: From 1,056,633 blunt trauma admissions, 1012 (0.1%) were identified with BAAI. The most common mechanism was motor vehicle accident (MVA; 57.5%). More than half the patients had at least one rib fracture (54.0%) or a spine fracture (53.9%), 20.8% had hypotension on admission, and 7.8% had a trunk abrasion. The average length of stay was 13.4 days and 24.6% required laparotomy, with 6.6% receiving an endovascular repair and 2.9% an open repair. Conclusions: In the largest nationwide series to date, BAAI continues to have a high mortality rate, with hemopneumothorax and inferior vena cava injury associated with the highest risk for mortality. The mechanism most strongly associated with BAAI is MVA, followed by pedestrian struck. Other risk factors for BAAI include rib fracture and trunk abrasion. Providers must maintain a high suspicion of injury for BAAI when these mechanisms of injury, physical examination findings, or image findings are seen.
Author Disclosures: B. Sheehan: Nothing to disclose; A. Grigorian: Nothing to disclose; C. de Virgilio: Nothing to disclose; R. M. Fujitani: Nothing to disclose; N. Kabutey: Nothing to disclose; M. Lekawa: Nothing to disclose; S. D. Schubl: Nothing to disclose; J. Nahmias: Nothing to disclose. Objective: Thoracic outlet syndrome (TOS) results from compression of the neurovascular structures in the thoracic outlet. Decompression provides relief of TOS symptoms, but little is known about long-term function and quality of life (QoL) from a patient's perspective. The purpose of this study was to evaluate surgical and QoL outcomes after surgical decompression of the thoracic outlet using a paraclavicular approach.
Differential Impact of Etiology on
Methods: We reviewed our prospectively maintained database of patients who underwent thoracic outlet decompression. Short-term outcomes were assessed by the Derkash classification using contingency table methods, and long-term outcomes including 12-Item Short Form Health Survey QoL were assessed by multiple regression. The 12-Item Short Form Health Survey was scored by published criteria, and scalespecific and aggregate mental and physical health-related QoL scores were computed. Aggregate QoL scores range from 0 (terrible) to 100 (perfect) and, for context, average 50 6 10 in the general population for this age group. Secondary outcomes included mortality, complications, and duration of hospital stay.
Results: Between August 2004 and August 2018, we performed 100 decompression procedures. Median age was 35 years (interquartile range, 24-47 years), and 58 (58%) were female. The mean duration of hospital stay was 4.48 days. The etiology of TOS was venous in 46, arterial in 8, neurogenic in 42, and mixed vascular and neurogenic in 4. Good or excellent Derkash results were reported in 77 (77%) patients (46/54 [85%] of those with vascular TOS vs 31/46 [67%] of those with neurogenic etiology; P < .036). Long-term QoL was obtained in 93 of 100 (93%), with a median duration from surgery of 6.1 (3.3-9.3) years. Patients with neurogenic TOS reported significantly lower aggregate mental health QoL than vascular TOS patients (57 vs 59; P < .016). This effect persisted across the entire duration of follow-up and was unaffected by time out from surgery (regression P for time ¼ .509). In contrast, aggregate physical function QoL was unaffected by neurogenic etiology (P ¼ .303), and all patients improved linearly with time (0.5 scale unit/y; P < .009). There were no deaths or injuries to the long thoracic nerve. Complications included pleural effusion or hemothorax requiring evacuation (n ¼ 6), phrenic nerve palsy (n ¼ 6), and lymph leak (n ¼ 2) treated with tube thoracostomy.
Conclusions: Neurogenic TOS is associated with significantly reduced short-term Derkash score. Patient-reported physical health QoL improves linearly with time from surgery regardless of etiology of TOS, whereas mental health QoL is severely affected in neurogenic TOS, and this effect does not improve over time.
Author Disclosures: Z. Al Rstum: Nothing to disclose; H. Sandhu: Nothing to disclose; C. Miller: Nothing to disclose; N. Saqib: Nothing to disclose; G. Martin: Nothing to disclose; J. Besho: Nothing to disclose; K. Charlton-Ouw: Nothing to disclose; A. Azizzadeh: Nothing to disclose. UA). Overall, CCAB had higher rates of stroke (2.6% vs 1.3%; P ¼ .002) and SDM (7.3% vs 3.5%; P < .001) but similar rates of MI (0.9% vs 1.6%; P ¼ .12) compared with ICEA. In SA, no difference was seen in stroke (1.2% for ICEA vs 1.9% for CCAB; P ¼ .36), MI (1.3% vs 1.4%; P ¼ .95), or SDM (2.9% vs 4.7%; P ¼ .13). In UA, no difference was seen in stroke (1.6% for ICEA vs 2.8% for CCAB; P ¼ .06), but ICEA had higher rates of MI (2.4% vs 0.7%; P ¼ .01) and CCAB had higher rates of SDM (5.5% vs 8.2%; P ¼ .01; Table) After logistic regression in the UA cohort, predictors of MI included ICEA (odds ratio [OR], 2.8; 95% confidence interval [CI], 1.1-7.1; P ¼ .03) and symptomatic status (OR, 2.0; 95% CI, 1.1-3.6; P ¼ .02); symptomatic status also predicted stroke (OR, 1.9; 95% CI, 1.04-3.6; P ¼ .04), but CCAB did not.
Conclusions: In patients with symptomatic CAD, both clinical CAD severity and operative strategy affect outcomes. In SA patients, CCAB does not increase perioperative morbidity. However, CCAB in UA patients prevents MI while not appreciably increasing stroke risk. This suggests that coronary revascularization before or concomitant with CEA should be considered in UA patients but that temporally prioritizing the treatment of one vascular bed over the other is less important in SA patients. 
